LFMDLifeMD, Inc.
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Re…
Industry Peers
Health Information Services| Headline | Source | Time |
|---|---|---|
Older | ||
 LifeMD (LFMD) Q2 2026 Earnings Call Transcript Revenue met guidance but profitability targets missed amid strategic restructuring. | ||
 LifeMD, Inc. Q2 2026 Earnings Call Summary Moby summary of LifeMD, Inc.'s Q2 2026 earnings call | ||
 LifeMD Q2 Earnings Call Highlights LifeMD (NASDAQ:LFMD) reported second-quarter revenue of $47.3 million, within its prior guidance range, while posting an adjusted EBITDA loss of approximately $3.5 million as elevated customer acquisition costs and a lower introductory price for branded GLP-1 care pressured profitability. Chairman | ||
 LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates LifeMD (LFMD) delivered earnings and revenue surprises of +20.00% and -3.70%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? | ||
 Medifast Q2 Earnings Call Highlights Medifast (NYSE:MED) reported second-quarter 2026 revenue of $76.4 million, down 27.6% from a year earlier, as its active earning coach base continued to decline amid the rapid adoption of GLP-1 medications across the traditional weight-loss category. The company posted a net loss of $3.1 million, or | ||